C12(n)-4-C12(n)·2Br头基尺寸对W/O微乳界面组成和结构的影响

合成出具有不同头基尺寸的季铵盐Gemini表面活性剂C12(n)-4-C12(n)·2Br(n=1, 2, 3时分别对应甲基、乙基和丙基, 即四亚甲基-α, ω-二(十二烷基二甲(乙、丙)基溴化铵)). 以稀释法研究C12(n)-4-C12(n)·2Br在庚烷中形成的W/O微乳的组成和结构. 结果表明, 庚烷溶液中的部分己醇参与构成混合界面膜, 从而改善了混合组分的分子几何形状, 生成了稳定的W/O微乳. 随着水含量W0增大, 微乳的水核也随之增大, 变小的界面曲率减小了混合膜对己醇量的需求. 增大C12(n)-4-C12(n)·2Br头基尺寸, 界面层中己醇与表面活性剂的摩尔比(a)先增大(n从1到2)然后再减小(n从2到3). W0愈大, a在n从2到3时减小得愈明显. 在W0=10和20时, 微乳水核半径Rw随n增大而减小; 但在W0=30时, 当n从2到3, Rw反倒明显增大. 这些结果表明, 季铵头基相连的两个丙基其行为与相连两个甲基或两个乙基时不同, 这两个丙基弯曲朝向庚烷, 撑大了表面活性剂烷烃链区域的体积, 致使混合界面膜上己醇分子的需求量减少, 有助于形成较大尺寸的水核.     

Gemini阳离子表面活性剂的合成及其胶束生成 Gemini阳离子表面活性剂的合成及其胶束生成

Cationic Gemini surfactants, alkanediyl-α,ω-bis(dimethyldodecylammonium bromide) have been synthesized by the following method: firstly dodecyl bromide was prepared by the reaction of dodecanol with bromic acid in the presence of strong sulfuric acid. Dodecylbromide was then reacted with N,N-tetramethyl ethane diamine(or N,N-tetramethyl hexana diamine) to prepare the title-compounds. Micellization of these Gemini surfactants was investigated using conductivity measurement. The results showed that the critical micelle concentration(cmc) of the Gemini surfactants has a much lower value compared with that of the corresponding “ monomer” . For a series of the Geminis with the same length(s) in the spacer chain, the cmc decreased with increasing the carbon number (m) in the alkyl chain. The aggregation number(N) of the micelle also drastically decreased with m. For the same value of m, the cmc varied slightly with s, which indicated that the electrostatic interaction between the ionic-groups of the “ monomer” has been naturally changed duo to a link between the two ionic-groups of the “ monomer” through a spacer. However, N was strongly decreased with s,which may be a reason of steric inhibition coming from the ionic-groups due to a link of spacer. With increasing temperature, micellization of the Gemini surfactants was slightly enhanced.     

Pluronic嵌段共聚物F127胶团对布洛芬的增溶(英文)

研究了PluronicF127胶团溶液对药物布洛芬(IBU)的增溶作用.通过芘探针荧光法测定了不同温度下F127在水溶液和0.01mo·lL-1pH7.4磷酸盐缓冲生理(PBS)溶液中的临界胶束浓度(cmc),采用高效液相色谱(HPLC)测定了F127溶液中布洛芬的溶解度,并依据公式计算了增溶参数(摩尔增溶量c和胶团-水分配系数K),考察了温度、溶剂和F68的加入对F127胶团化行为及其对布洛芬增溶作用的影响.结果表明:布洛芬的溶解度随F127质量分数的提高线性增加;随着温度升高,cmc急剧下降,胶团内核的疏水性增强,χ和K稍有增大;与水溶液相比,在PBS溶液中cmc减小,χ几乎不变,K显著降低;F68的加入对F127胶团的性质几乎无影响,对增溶的影响也不明显.对增溶参数的分析表明,K反映的是药物布洛芬的性质,χ则可反映嵌段共聚物F127的溶解效能,并证实了布洛芬是通过F127胶团的内核和栅栏层而实现增溶的.     

C12-s-C12•2Br在正庚烷中反胶团形成及增溶水特性

在助表面活性剂正己醇存在下, 季铵盐Gemini表面活性剂C12-s-C12•2Br(s=2、3、4、5、6、8、12)在正庚烷中形成了反胶团. 以水增溶法测定了临界反胶团浓度cmcw, 这些cmcw均分别小于它们在水中生成正胶团的临界浓度cmcaq. cmcw随s的变化规律与cmcaq随s的变化规律类似, 在s=4时出现极大值. 由水增溶法和电导法获得的反胶团饱和增溶水量(mw或mc)约在s=5时出现最大值. 这些现象被归结为联接链构型的变化.